Preferences help
enabled [disable] Abstract
Number of results
2016 | 6 | 1 | A8-10
Article title

Bone marrow transplantation – how can we maximize cardiac status?

Title variants
Languages of publication
Physical description
  • University of Pennsylvania, Abramson Cancer Center, Philadelphia, United States
  • 1. Jones LW, Haykowsky MJ, Swartz JJ et al. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007; 50(15): 1435-1441.
  • 2. Lakoski SG, Eves ND, Douglas PS, Jones LW. Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol 2012; 9(5): 288-296.
  • 3. Jones LW, Courneya KS, Mackey JR et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol 2012; 30(20): 2530-2537.
  • 4. Jones LW, Liu Q, Armstrong GT et al. Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: a report from the childhood cancer survivor study. J Clin Oncol 2014; 32(32): 3643-3650.
  • 5. Khouri MG, Hornsby WE, Risum N et al. Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy. Breast Cancer Res Treat 2014; 143(3): 531-539.
  • 6. Khouri MG, Douglas PS, Mackey JR et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation 2012; 126(23): 2749-2763.
  • 7. CIBMTR – Center for International Blood and Marrow Transplant Research [online:].
  • 8. Nakamura R, Palmer JM, Chao J et al. Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (RI-HCT) For MDS Using Tacrolimus/Sirolimus As GVHD Prophylaxis. Biol Blood Marrow Transpl 2010; 16: S273-S274.
  • 9. Passweg JR, Baldomero H, Bader P et al. European Society for Blood and Marrow Transplantation (EBMT). Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidenticaldonors but fewer cord blood transplants. Bone Marrow Transplant 2015; 50(4): 476-482.
  • 10. Luznik L, Bolaños-Meade J, Zahurak M et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood. 2010; 115(16): 3224-3230.
  • 11. Ciurea SO, Zhang MJ, Bacigalupo AA et al. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. Blood 2015; 126(8): 1033-1040.
  • 12. Fradley MG, Moslehi J. QT Prolongation and Oncology Drug Development. Card Electrophysiol Clin 2015; 7(2): 341-355.
  • 13. Naing A, Veasey-Rodrigues H, Hong DS et al. Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs. Ann Oncol 2012; 23(11): 2960-2963.
  • 14. Miller WP, Shanley R, Dorostkar P. Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center. Bone Marrow Transplant 2015; 50(7): 954-960.
  • 15. O’Neal WT, Lakoski SG, Qureshi W et al. Relation between cancer and atrial fibrillation (from the Reasons for Geographic And Racial Differences in Stroke Study). Am J Cardiol 2015; 115(8):1090-1094.
  • 16. Feliz V, Saiyad S, Ramarao SM et al. Melphalan-induced supraventricular tachycardia: incidence and risk factors. Clin Cardiol 2011; 34(6): 356-359.
  • 17. Singla A, Hogan WJ, Ansell SM et al. Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2013; 19(8): 1233-1237.
  • 18. Tonorezos ES, Stillwell EE, Calloway JJ et al. Arrhythmias in the setting of hematopoietic cell transplants. Bone Marrow Transplant 2015; 50(9): 1212-1216.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.